Cargando…
Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability
Targeted radionuclide therapy (TRNT) is a promising approach for cancer therapy. Terbium has four medically interesting isotopes ((149)Tb, (152)Tb, (155)Tb and (161)Tb) which span the entire radiopharmaceutical space (TRNT, PET and SPECT imaging). Since the same element is used, accessing the variou...
Autores principales: | Cassells, Irwin, Ahenkorah, Stephen, Burgoyne, Andrew R., Van de Voorde, Michiel, Deroose, Christophe M., Cardinaels, Thomas, Bormans, Guy, Ooms, Maarten, Cleeren, Frederik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422959/ https://www.ncbi.nlm.nih.gov/pubmed/34504849 http://dx.doi.org/10.3389/fmed.2021.675122 |
Ejemplares similares
-
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
por: Ahenkorah, Stephen, et al.
Publicado: (2021) -
3p-C-NETA: A versatile and effective chelator for development of Al(18)F-labeled and therapeutic radiopharmaceuticals
por: Ahenkorah, Stephen, et al.
Publicado: (2022) -
A simple and automated method for (161)Tb purification and ICP-MS analysis of (161)Tb
por: McNeil, Scott W., et al.
Publicado: (2022) -
D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
por: Luyten, Kaat, et al.
Publicado: (2021) -
Terbium-161 for PSMA-targeted radionuclide therapy of
prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)